Table 1 Demographics of study population (n = 1133)
Characteristic | No. (%) |
|---|---|
Sex | |
Male | 540 (48.5) |
Female | 573 (51.5) |
Age (year) | |
<4 | 278 (24.5) |
4–9 | 248 (21.9) |
10–13 | 271 (23.9) |
≥14 | 336 (29.7) |
Race | |
Caucasian | 915 (80.8) |
African–American | 132 (11.7) |
Other | 86 (7.5) |
Primary indications for EGDa | |
Abdominal pain | 622 (54.9) |
Emesis | 361 (31.9) |
Nausea | 258 (22.8) |
Failure to thrive/weight loss | 177 (15.6) |
Allergies | 153 (13.5) |
Positive celiac antibodies | 146 (12.9) |
Diarrhea | 142 (12.5) |
Dysphagia | 133 (11.7) |
Heartburn | 127 (11.2) |